Advertisement

Intraoperativer Volumenersatz, Transfusion und Behandlung von Gerinnungsstörungen

Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Sowohl der operative Eingriff als auch die Narkose führen zu Veränderungen des intravasalen Volumenstatus des Patienten. Ziele der perioperativen Flüssigkeits- bzw. Volumentherapie sind die Aufrechterhaltung des zirkulierenden intravasalen Volumen (Normovolämie), einer adäquaten Gewebeperfusion und -oxygenierung, des Gleichgewichts im Elektrolythaushalt sowie die Aufrechterhaltung der Normoglykämie.

Literatur

  1. 1.
    Marik PE, Baram M, Vahid B (2008) Does the central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of the seven mares. Chest 134:172–178CrossRefPubMedGoogle Scholar
  2. 2.
    S3-Leitlinien „Intravasale Volumentherapie beim Erwachsenen“ der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin, AWMF-Register-Nr.001/020, 2014Google Scholar
  3. 3.
    Dunham CM, Siegel JH, Weireter L et al (1991) Oxygen debt and metabolic acedemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med 19:231–243CrossRefPubMedGoogle Scholar
  4. 4.
    Staab DB, Sorensen VJ, Fath JJ et al (1999) Coagulation defects resulting from ambient temperature-induced hypothermia. J Trauma 36:634–638CrossRefGoogle Scholar
  5. 5.
    Kurz A, Sessler DI, Lenhard R (1996) Perioperative normothermia to reduce the incidence of surgical wound infection and shorten hospitalization. N Engl J Med 334:1209–1215CrossRefPubMedGoogle Scholar
  6. 6.
    De Lorenzo C, Calatzis A, Welsch U, Heindl B (2006) Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6 %. Anesth Analg 102:1194–1200CrossRefPubMedGoogle Scholar
  7. 7.
    Scheingraber S, Rehm M, Sehmisch C, Finsterer U (1999) Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90:1265–1270CrossRefPubMedGoogle Scholar
  8. 8.
    Bundesärztekammer auf Empfehlung ihres wissenschaftlichen Beirates (2014) Querschnittsleitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 4., überarb. Aufl. Deutscher Ärzteverlag, KölnGoogle Scholar
  9. 9.
    Hourfar MK, Jork C, Schottstedt V et al (2008) Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus. Transfusion 48:1558–1566CrossRefPubMedGoogle Scholar
  10. 10.
    Karger R, Kretschmer V, Wulf H (2004) Risiken der Transfusion von Blutkomponenten: Aktuelle Anhaltszahlen für eine „quantitative“ Risikoaufklärung. Anästh Intensivmed 45:430–434Google Scholar
  11. 11.
    Vamvakas EC, Blajchman MA (2010) Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 24:77–124CrossRefPubMedGoogle Scholar
  12. 12.
    Vorstand der Bundesärztekammer (2010) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Deutscher Ärzteverlag. ISBN-Nr. 978-3-7691-1294-8Google Scholar
  13. 13.
    Moore SB (2006) Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med 34:S114–S117CrossRefPubMedGoogle Scholar
  14. 14.
    Gajic O, Gropper MA, Hubmayr RD (2006) Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 34:S109–S113CrossRefPubMedGoogle Scholar
  15. 15.
    Taylor RW, O’Brian J, Trottier SJ et al (2006) Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 34:2302–2308CrossRefPubMedGoogle Scholar
  16. 16.
    Atzil S, Arad M, Glasner A et al (2008) Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 109:989–997CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Heiss MM, Mempel W, Delanoff C et al (1994) Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12:1859–1867CrossRefPubMedGoogle Scholar
  18. 18.
    Shander A, Hofmann A, Ozawa S et al (2010) Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50:753–765CrossRefPubMedGoogle Scholar
  19. 19.
    Carson JL, Duff A, Poses RM et al (1996) Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348:1055–1060CrossRefPubMedGoogle Scholar
  20. 20.
    Goodnough LT, Maniatis A, Earnshaw P et al (2011) Detection, evaluation and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 106:13–22CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Kozek-Langenecker SA, Afshari A, Albaladejo P et al (2013) Management of severe perioperative bleeding. Guidelines from the European Society of Anesthesiology. Eur J Anaesthesiol 30:270–382CrossRefPubMedGoogle Scholar
  22. 22.
    Gogarten W, Vandermeulen E et al (2010) Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 27:999–1015CrossRefPubMedGoogle Scholar
  23. 23.
    Thomas MJG, Gillon J, Desmond MJ (1996) Preoperative autologous donation. Transfusion 36:633–639CrossRefPubMedGoogle Scholar
  24. 24.
    Penner M, Sibrowski W (1994) Nutzen und Risiken der Eigenblutspende. Infusionsther Transfusionsmed 21(suppl 1):64–68PubMedGoogle Scholar
  25. 25.
    Friedman BA, Oberman HA, Chadwick AR, Kingdon KI (1976) The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 16:380–387CrossRefPubMedGoogle Scholar
  26. 26.
    European Commission, Sirchia G, Giovanetti AM, McClelland B, Fraccia GN (1994) Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. European Commission, LuxembourgGoogle Scholar
  27. 27.
    Habler O, Schwenzer K, Zimmer K et al (2004) Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. Int J Oral Maxillofac Surg 33:467–475CrossRefPubMedGoogle Scholar
  28. 28.
    Kick O, Daniel E (1997) Mathematical considerations in the practice of acute normovolemic hemodilution. Transfusion 37:141–143CrossRefPubMedGoogle Scholar
  29. 29.
    Egli GA, Zollinger A, Seifert B et al (1997) Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 78:684–689CrossRefPubMedGoogle Scholar
  30. 30.
    American Society of Anesthesiologists (2006) Practice guidelines for blood transfusion and adjuvant therapies. Anesthesiology 105:198–208CrossRefGoogle Scholar
  31. 31.
    College of American Pathologists (1998) Practice parameter for the use of red blood cell transfusions. Arch Pathol Lab Med 122:130–138Google Scholar
  32. 32.
    Bryson GL, Laupacis A, Wells GA, The International Study of Perioperative Transfusion (1998) Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A Meta-analysis. Anesth Analg 86:9–15PubMedGoogle Scholar
  33. 33.
    Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E (2004) Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44:632–644CrossRefPubMedGoogle Scholar
  34. 34.
    Monk TG, Goodnough LT, Brecher ME et al (1999) A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 91:24–33CrossRefPubMedGoogle Scholar
  35. 35.
    Van Daele MERM, Trouwborst A, Van Woerkens LCSM et al (1994) Transoesophageal echocardiographic monitoring of preoperative acute hypervolemic hemodilution. Anesthesiology 81:602–609CrossRefPubMedGoogle Scholar
  36. 36.
    Mielke LL, Entholzner EK, Kling M et al (1997) Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: an alternative to acute normovolemic hemodilution? Anesth Analg 84:26–30CrossRefPubMedGoogle Scholar
  37. 37.
    Habler O, Meier J, Pape A et al (2006) Perioperative Anämietoleranz – Mechanismen, Einflussfaktoren, Grenzen. Anaesthesist 55:1142–1156CrossRefPubMedGoogle Scholar
  38. 38.
    Gombotz H (2003) Physiologische Grenzen der Verdünnungsanämie bei Intensivpatienten. J Anästh Intensivmed 1:84–87Google Scholar
  39. 39.
    Mauermann WJ, Shilling AM, Zuo Z (2006) A comparison of neuroaxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg 103:1018–1025CrossRefPubMedGoogle Scholar
  40. 40.
    Choi WS, Samman N (2008) Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 37:687–703CrossRefPubMedGoogle Scholar
  41. 41.
    Endrich B, Franke N, Peter K, Messmer K (1987) Induced hypotension: action of sodium nitroprusside and nitroglycerin on the microcirculation. Anesthesiology 66:605–613CrossRefPubMedGoogle Scholar
  42. 42.
    Hansen E, Knuechel R, Altmeppen J, Taeger K (1999) Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 39:608–615CrossRefPubMedGoogle Scholar
  43. 43.
    Geoghegan J, Daniels JP, Moore P et al (2009) Cell salvage at caesarean section: the need for an evidence-based approach. BJOG 116:743–747CrossRefPubMedGoogle Scholar
  44. 44.
    Carless PA, Hentry DA, Moxey AJ et al (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 4:CD001888Google Scholar
  45. 45.
    Dirkmann D, Hanke A, Görlinger K, Peters J (2008) Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 106:1627–1632CrossRefPubMedGoogle Scholar
  46. 46.
    Jones R, Moulton CE, Hardy KJ (1998) Central venous pressure and its effects on blood loss during liver resection. Br J Surg 85:1058–1060CrossRefPubMedGoogle Scholar
  47. 47.
    Fergusson DA, Hebert PC, Mazer CD et al (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358:2319–2331CrossRefPubMedGoogle Scholar
  48. 48.
    Hiippala ST, Myllylä GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–365PubMedGoogle Scholar
  49. 49.
    Grashey R, Mathonia P, Mutschler W, Heindl B (2007) Durch Thrombelastographie gesteuertes perioperatives Gerinnungsmanagement. Unfallchirurg 110:259–263CrossRefPubMedGoogle Scholar
  50. 50.
    Habler O (2015) Management akuter Blutverluste ohne Point-of-Care (POC)-Monitoring. In: Eckart J, Forst H, Briegel J (Hrsg) Intensivmedizin. Ecomed-Storck Verlag, Hamburg; 70. Erg.-Lfg.; IX-6.5:1–16Google Scholar
  51. 51.
    Bunn HF, May MH, Kochalaty WF, Shields CE (1969) Hemoglobin function in stored blood. J Clin Invest 48:311–321CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Fitzgerald RD, Martin CM, Dietz GE et al (1997) Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 25:726–732CrossRefPubMedGoogle Scholar
  53. 53.
    Marik PE, Sibbald WJ (1993) Effects of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269:3024–3029CrossRefPubMedGoogle Scholar
  54. 54.
    Koch CG, Li L, Sessler DI et al (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358:1229–1239CrossRefPubMedGoogle Scholar
  55. 55.
    Roback JD, Caldwell S, Carson J et al (2010) Evidence-based practice guidelines for plasma transfusion. Transfusion 50:1227–1239CrossRefPubMedGoogle Scholar
  56. 56.
    Habler O, Pape A, Meier J, Zwißler B (2005) Künstliche Sauerstoffträger als Alternative zur Bluttransfusion. Anaesthesist 54:741–754CrossRefPubMedGoogle Scholar
  57. 57.
    Habler O, Voß B (2010) Perioperatives Management bei Zeugen Jehovas. Anaesthesist 59:297–311CrossRefPubMedGoogle Scholar

Copyright information

© © Springer-Verlag GmbH Deutschland 2016

Authors and Affiliations

  1. 1.Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Krankenhaus NordwestFrankfurt am MainDeutschland

Personalised recommendations